OUD
VUMC SHINEs on the Needs of Infants and Young Children Exposed to Opioids In Utero
On the heels of the success of its Firefly Program—which was founded in 2021 to provide multidisciplinary ...
AUGUST 21, 2025
New Online Curriculum Aims at Educating Appalachia on Opioids
A Philadelphia-based nonprofit foundation aims to reduce opioid overdoses and related fatalities in one of the ...
MARCH 13, 2025
Endocannabinoids Show Promise in Blunting Opioid Reward, Preserving Pain Relief
Investigators have begun studying the role that endocannabinoids play in addressing opioid addiction by ...
FEBRUARY 5, 2025
Better Algorithms Needed for Predicting Opioid Use Disorder
There is a need for more robust data and improved machine learning techniques to accurately assess the genetic risk ...
JANUARY 17, 2025
FDA Issues New Guidance, Clarifies Confusion on Buprenorphine Labeling
The FDA has issued new guidance for labeling buprenorphine-containing transmucosal products that seeks to clarify ...
JANUARY 16, 2025
FDA Details Continued Risk, Benefit Assessments of Devices for OUD
A committee is updating a 2019 risk−benefit analyses of devices to better understand patient preferences, and ...
JANUARY 2, 2025
CDC Funding to Help Health Systems Address Opioid Use Disorder
The American Hospital Association has been awarded a nearly $1.5 million grant from the CDC as part of its National ...
OCTOBER 30, 2024
NIH: More Than Half of U.S. Jails Don’t Have Access to Medication for OUD
New research has found over half of more than 1,000 surveyed U.S. jails did not offer medications for OUD to its ...
SEPTEMBER 26, 2024
Telehealth May Ease Some Stigma Linked to Treatment for OUD
A qualitative analysis of patient perceptions of stigma and their experiences with it while using telehealth for ...
SEPTEMBER 13, 2024
Pharmacist Inclusion in OUD Treatment Teams Benefits Patients
Incorporating pharmacists into OUD treatment improves patient outcomes and boosts efficiency in the healthcare ...
SEPTEMBER 5, 2024
Is Weekly Methadone and Long-Acting OUD Therapy in Our Future Arsenal? Insights From Dr. Nora Volkow
The National Institute on Drug Abuse is undertaking studies on medically assisted treatment programs and opioid use ...
AUGUST 26, 2024
Few Studies and Variable Opioid Misuse Rates in Cancer Patients Highlight Need for Better Research
The prevalence of opioid misuse risk varied between 2.4% and 35.4%, with a pooled prevalence of 12.3%.
AUGUST 6, 2024
